# 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

> **NCT04250636** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 6 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** 3BNC117-LS
- **DRUG:** 10-1074-LS

## Key facts

- **NCT ID:** NCT04250636
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-13
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-02-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04250636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04250636, "3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04250636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*